Document is current
Any future updates will be listed below
-
Authors
Collins, Kelsey H. https://orcid.org/0000-0001-7348-7348
Haugen, Ida K. https://orcid.org/0000-0001-7810-2216
Neogi, Tuhina https://orcid.org/0000-0002-9515-1711
Guilak, Farshid https://orcid.org/0000-0001-7380-0330
- License Information
-
More Information
Article History
Accepted: 14 November 2025
First Online: 3 December 2025
Competing interests
: K.H.C. declares no competing interests. I.K.H. has received personal fees (consultancies and speaker honorarium) from Argenx, Pacira, Grünenthal, Abbvie and GSK for work unrelated to this manuscript. F.G. is a founder, shareholder and employee of Cytex Therapeutics, unrelated to this manuscript. T.N. has served as a consultant for Novartis and Merck for work unrelated to this manuscript.
